Diabetic Nephropathy

Image

Diabetic nephropathy (diabetic kidney disease) is kidney damage that results from having diabetes.

Having high blood glucose levels due to diabetes can damage the part of the kidneys that filters your blood. The damaged filter becomes ‘leaky’ and lets protein into your urine.

Symptoms

Diabetic nephropathy usually has no symptoms early on. You can’t tell that there is protein in your urine – it’s something that is detected with a urine test.

It can take many years for the kidney damage to progress. Symptoms usually only appear when kidney damage has deteriorated significantly. Even then, the symptoms tend to be vague.

If the kidney damage becomes severe, you may notice:

  • weight loss;
  • a poor appetite or feeling sick;
  • swollen ankles and feet (due to retaining fluid);
  • puffiness around the eyes;
  • dry, itchy skin;
  • muscle cramps;
  • needing to pass urine more often;
  • feeling tired; and
  • having difficulty concentrating.

Risk factors for diabetic nephropathy

There are many factors that can increase your risk of developing diabetic nephropathy. These include:

  • the length of time that you have had diabetes;
  • having high blood glucose levels (because your diabetes is not well managed);
  • having high blood pressure;
  • being overweight or obese; and
  • smoking.

The Journal of Clinical Nephrology and Therapeutics  publishes scientific manuscripts that are directly or indirectly based on variegated aspects of clinical nephrology, diabetic nephropathy, pediatric nephrology, renal physiology, renal histopathology, immunobiology, intensive care nephrology and ischemic nephropathy.

The journal most specifically emphasizes on the propagation of research developments that may contribute in the furtherance of research and clinical implementation of novel tools as well as adept clinical techniques including renal transplantation, dialysis, diagnostic kidney imaging, aging and kidney disease, hemodialysis, body fluid volume composition, nephron endowment and erythropoietin therapy.

The journal accepts original submissions in the form of Research Articles, Review Articles, Short Communications, Opinion Articles, Case Reports and Commentaries. Acceptance or rejection of the manuscript solely depends upon the comments of independent reviewers. Positive review by at least two reviewers is mandatory for the acceptance and publication of any citable manuscript.

You may submit manuscripts as an email attachment to the following mail-id: clinnephrol@emedscholar.com

Kind Regards,
Mercedes Rose
Editorial Team

Journal of Clinical Nephrology and Therapeutic

WhatsApp: +44 1470-490003